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Background: Meta-analysis has become a popular approach for high-throughput genomic data analysis because it
often can significantly increase power to detect biological signals or patterns in datasets. However, when using
public-available databases for meta-analysis, duplication of samples is an often encountered problem, especially for
gene expression data. Not removing duplicates could lead false positive finding, misleading clustering pattern or
model over-fitting issue, etc in the subsequent data analysis.
Results: We developed a Bioconductor package Dupchecker that efficiently identifies duplicated samples by
generating MD5 fingerprints for raw data. A real data example was demonstrated to show the usage and output of
the package.
Conclusions: Researchers may not pay enough attention to checking and removing duplicated samples, and then
data contamination could make the results or conclusions from meta-analysis questionable. We suggest applying
DupChecker to examine all gene expression data sets before any data analysis step.Background
Publicly available high-throughput genomic data, espe-
cially gene expression data, have greatly changed the way
genomic research is conducted recently. The major online
databases such as the Gene Expression Omnibus (GEO)
[1] ArrayExpress [2], and Sequence Read Archive (SRA)
[3] have collected more than one million samples. Not
only do these datasets allow the researchers to find rele-
vant individual data set for biomarker validation pur-
pose, multiple data sets can also be combined to increase
statistical power to detect the biological patterns that are
hidden in one or few datasets with small sample sizes. For
example, several studies integrated multiple public avail-
able microarray gene expression data to discover new
cancer subtypes [4-7]. However, one challenge for gene
expression meta-analysis is duplication of samples. In
GEO, each individual data set with a unique GEO acces-
sion number is associated with a study or publication* Correspondence: xi.steven.chen@gmail.com
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The gene expression data sets with different accession
numbers may contain duplicated samples linked to mul-
tiple sample accession numbers. For large-scale gene ex-
pression meta-analysis involving hundreds of data sets,
the number of duplicated samples may be large.
It is very easy to ignore removal of the duplicated gene
expression samples in curated high-throughput data, and
the consequences could be obtaining false positive find-
ings or misleading cluster patterns, etc. If the duplicated
samples were in both training and testing cohorts for gene
signature validation study, it would lead over-fitting of the
classifier.
Nevertheless, the identification of duplicated samples
could be complicated and labor intensive. For micro-
array gene expression data, if the preprocessing, normali-
zation and transformation procedures used are different,
the normalized datasets for duplicated samples may
not be identical. We developed a bioconductor pack-
age DupChecker that can efficiently check sample redun-
dancy based on the raw data files of high-throughput
genomic data.Ltd. This is an Open Access article distributed under the terms of the Creative
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The method that we implemented in DupChecker is to
examine MD5 hash for each raw data file. MD5 is a
message-digest algorithm that can be utilized to check
data integrity by producing 128-bit fingerprint of the
data input (Rivest, 1992). The duplicated gene expression
samples can be identified by checking to see if they have
identical MD5 fingerprints.
For users’ convenience, we also developed the func-
tions geoDownload and arrayExpressDownload to down-
load multiple gene expression data sets from GEO or
ArrayExpress databases and deposit the files under the
specified directory. The functions buildFileTable and
validateFile will go through each raw data files under
the directory to calculate MD5 fingerprint and return
a table listing all duplicated samples.
Result
We applied the DupChecker package to three colon can-
cer Affymetrix gene expression data sets - GSE13067,
GSE14333 and GSE17538 from GEO with 74, 290 and
244 samples respectively. Both GSE13067 and GSE14333
were contributed from the same laboratory in Australia,
and GSE17538 was from an institute in the US. The
raw data in Affymetrix CEL file format were needed
for DupChecker analysis. From the final summary table
generated by the validateFile function, we found there
were 64, 231 and 167 duplicated samples in each data set
compared with the other two data sets. Table 1 displays
the first few rows of the summary table and the full sum-
mary table was listed in Additional file 1. The first column
shows the MD5 fingerprint values for the samples with
duplications. The rest of the columns are CEL file names
for duplications.
The DupChecker package is computationally efficient.
After downloading CEL files for these three data sets, it
took less than one minute to calculate MD5 fingerprints
for all 608 files and to deliver a summary table using a
2.7GHz Intel Core i7 CPU.
We also tested DupChecker package on 2 ArrayExpres
and 22 GEO breast cancer datasets containing 5203 affy-
metrix CEL files. Among those files, 696 CEL files were
actually duplicated from 348 CEL files. The full sum-






023c4e4f9ebfc09b838a22f2a7bdaa59files 2 and 3. It took around 3 hours on a computer
running 64-bit Windows 7 with 2.00GHz Intel® Xeon®
E5-2620 CPU and 32.0 GB memory to finish the whole
process.Conclusions
Gene expression meta-analysis has become increasingly
popular for high-throughput genomic data analysis. Due
to the large amount of publicly available gene expression
data contributed by different researchers, it is almost in-
evitable to include duplicated samples in the data sets
collected for meta-analysis. In the example we showed
in Section 3, among the three GEO data sets, there were
463 out of 608 samples with at least one duplicate. It
was difficult to tell by IDs since all duplicate samples
had different GEO accession numbers. It is effective to
identify duplications using MD5 fingerprint generated
from raw data since it would not involve any gene ex-
pression data processing procedures.
Researchers may not pay enough attention to checking
and removing duplicated samples, and then data con-
tamination could make the results or conclusions from
meta-analysis questionable. We suggest applying Dup-
Checker to examine all gene expression data sets before
any data analysis step. We also want to point out that
the data files must be identical to be identified as dupli-
cates. Specimens or RNA samples profiled twice, whe-
ther on the sample platform or different platforms, will
not be identified using DupChecker.
In this application note, we illustrated the applica-
tion using gene expression data, but DupChecker package
can also be applied to other types of high-throughput
genomic data including next-generation sequencing data.Availability and requirements
Project name: DupChecker
Project home page: http://www.bioconductor.org/packages/
devel/bioc/html/DupChecker.html
Programming languages: R
Operating system(s): Platform independent
Other requirement: Bioconductor 3.0 or higher
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Additional file 1: The full result table generated by DupChecker for
the colon cancer data.
Additional file 2: The full result table generated by DupChecker for
the breast cancer data.
Additional file 3: The R code for breast cancer example.
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